Dusan Stefoski to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Dusan Stefoski has written about Dose-Response Relationship, Drug.
Connection Strength
0.060
-
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial. Lancet Neurol. 2014 May; 13(5):472-81.
Score: 0.028
-
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial. Lancet. 2013 Jun 22; 381(9884):2167-75.
Score: 0.027
-
Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol. 1990 Feb; 27(2):186-92.
Score: 0.005